ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• How EDC-Based SAE Reporting Reduces Time To Detection And Response

  Serious adverse events (SAEs) play a pivotal role in patient safety during clinical trials, and the right EDC system helps you efficiently track and manage the entire lifecycle of SAE reporting.

• RTSM: Randomization And Cohort Management, IP Inventory Management

  Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

• Reduce Time, Cost, & Risk With Clinical Study Data Review Software

  See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.

• How eConsent Can Help Legally Authorized Representatives

  Software vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.

• Sustainable Clinical Trials Through eClinical Innovation

  Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.

• eCOA Predictions For 2022

  Dive into the prediction that the rapid adoption of eCOAs will continue to grow in 2022, as sponsors acknowledge how useful these tools have become in decentralized clinical trial (DCT) settings.

• The Power Of Adaptive Learning

  Delve into the details of this approach to training, which addresses common complaints, and how it holds promise for enhancing the efficiency and performance of clinical research staff.

• The Future Of EDC Systems

  Gain insight from EDC users in sponsor organizations and CROs regarding anticipated trends in the next two years and how EDC systems can align with decentralized clinical trials.

• Your CRAs Aren't Monitoring. They're Managing Workarounds.

  CRA productivity rises when monitoring shifts from manual tasks to streamlined access, standardized workflows, and proactive oversight — freeing time for engagement, data quality, and patient safety.

• 6 Key Ways Real-World Data Is Accelerating Breast Cancer Therapies

  Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.